Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
NCT ID: NCT04725357
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
96 participants
INTERVENTIONAL
2021-01-25
2022-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opioid-Free Pain Protocol After Shoulder Arthroplasty
NCT05488847
Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair
NCT05974423
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
NCT05291598
The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty
NCT04003350
Efficacy of Methylprednisolone for Pain Control After ACL Repair
NCT07158476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arthroscopic Labral Repair + postoperative Meloxicam
After surgery participants will receive a prescription of 20 pills of 15 mg Meloxicam
Meloxicam 15 mg
Participants will receive a prescription of 20 pills of 15 mg Meloxicam after surgery
Preoperative Interscalene Nerve Block
Preoperatively participants will standardly receive an interscalene nerve block
arthroscopic labral repair
participant will have their standard surgical procedure done
Arthroscopic Labral Repair without Meloxicam
After surgery participants will receive a prescription of 20 pills of 5/300 mg vicodin (hydrocodone/acetaminophen)
Preoperative Interscalene Nerve Block
Preoperatively participants will standardly receive an interscalene nerve block
arthroscopic labral repair
participant will have their standard surgical procedure done
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meloxicam 15 mg
Participants will receive a prescription of 20 pills of 15 mg Meloxicam after surgery
Preoperative Interscalene Nerve Block
Preoperatively participants will standardly receive an interscalene nerve block
arthroscopic labral repair
participant will have their standard surgical procedure done
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for arthroscopic labrum repair of the shoulder
Exclusion Criteria
* Currently on long-term preoperative narcotics
* Scheduled for revision arthroscopic repairs of the shoulder
* Unable/unwilling to consent for enrollment
* Unable to complete postoperative surveys
* History of chronic pain syndromes (fibromyalgia, chronic diffuse MSK pain, etc)
* Patients under the age of 18
* Pregnant or breastfeeding women
* Scheduled for concurrent procedures
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rothman Institute Orthopaedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JHOR20D.1216
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.